Heparin and Related Polysaccharides

  • David A. Lane
  • Ingemar Björk
  • Ulf Lindahl

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 313)

Table of contents

  1. Front Matter
    Pages i-x
  2. Historical Aspects

    1. Lennart Rodén, Sandya Ananth, Patrick Campbell, Tracy Curenton, Göran Ekborg, Stephen Manzella et al.
      Pages 1-20
  3. Structural Properties of Heparin and Heparan Sulphate

  4. Heparin and Heparan Sulphate Proteoglycanscellular Aspects

  5. Heparin and Heparan Sulphate Proteoglycansinteractions and Metabolism

    1. Lena Kjellén, Inger Pettersson, Erik Unger, Ulf Lindahl
      Pages 107-111
    2. Craig Freeman, John Hopwood
      Pages 121-134
    3. George D. Manley, Thomas J. Owen, John L. Krstenansky, Robert G. Brankamp, Alan D. Cardin
      Pages 135-140
    4. Fanyu Zhou, Teresia Höök, John A. Thompson, Magnus Höök
      Pages 141-153
  6. Anticoagulant Proteins

    1. John F. Parkinson, Takatoshi Koyama, Nils U. Bang, Klaus T. Preissner
      Pages 177-188
    2. George J. Broze Jr., Robin Wesselschmidt, Darryl Higuchi, Thomas Girard, Karen Likert, Louise MacPhail et al.
      Pages 189-197
    3. Ulrich Abildgaard
      Pages 199-204
  7. Antithrombotic Mechanisms

  8. Clinical Use

  9. New Perspectives

    1. Dennis D. Cunningham, Steven L. Wagner, David H. Farrell
      Pages 297-306
    2. I. Vlodavsky, R. Ishai-Michaeli, M. Mohsen, R. Bar-Shavit, R. Catane, H.-P. T. Ekre et al.
      Pages 317-327
    3. Hans-Peter Ekre, Yaakov Naparstek, Ofer Lider, Pia Hydén, Östen Hägermark, Torbjörn Nilsson et al.
      Pages 329-340
    4. Patricia G. Spear, Mei-Tsu Shieh, Betsy C. Herold, Darrell WuDunn, Thomas I. Koshy
      Pages 341-353
  10. Back Matter
    Pages 365-374

About this book


This volume is a record of a meeting entitled "Heparin and Related Polysaccharides" that was held at the Biomedical Center, Uppsala, Sweden between 1-6 September 1991. The meeting was hosted by U. Lindahl, L. Kjellen and I. Bjork, who were helped in their preparations by a scientific advisory panel that included U. Abildgaard, B. Casu, E. Holmer and D. Lane. Altogether, 230 participants from 18 countries attended the meeting, and most were present to be included in a photograph, which is to be found at the end of this volume. The selection of presentations for inclusion in the Symposia of the meeting was made on the basis of the known high quality of the work of the individuals or groups involved. This, we believe, is reflected in the contents of the enclosed articles, which collectively give a comprehensive overview of the present state of knowledge of heparin and related compounds. Some of the areas covered are evolving or controversial and the views expressed in each article should be regarded as those of the author(s). The authors have taken various amounts of care to define all their abbreviations and some familiarity with the different forms of nomenclature used in the fields of polysaccharide chemistry and of the coagulation proteinases and their inhibitors will assist the reader.


Activation Migration Polysaccharid Regulation Vivo enzymes metabolism plasma membrane

Editors and affiliations

  • David A. Lane
    • 1
  • Ingemar Björk
    • 2
  • Ulf Lindahl
    • 3
  1. 1.Charing Cross and Westminster Medical SchoolLondonUK
  2. 2.The Swedish University of Agricultural SciencesUppsalaSweden
  3. 3.Uppsala UniversityUppsalaSweden

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1992
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4899-2446-9
  • Online ISBN 978-1-4899-2444-5
  • Series Print ISSN 0065-2598
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods